Chemours (CC) Cost of Revenue (2014 - 2026)

Chemours' Cost of Revenue history runs 13 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• In Q1 2026, Cost of Revenue rose 3.27% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $4.9 billion (up 5.28% YoY), while the FY2025 annual figure was $4.9 billion, up 5.73% from the prior year.
• Cost of Revenue was $1.2 billion for Q1 2026 at Chemours, roughly flat from $1.2 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $1.4 billion in Q2 2022 to a low of $1.1 billion in Q1 2024.
• Historically, Cost of Revenue has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue increased 12.2% in 2022, then slipped 11.85% in 2023.
• A 5-year view of Cost of Revenue shows it stood at $1.1 billion in 2022, then declined by 2.11% to $1.1 billion in 2023, then fell by 1.71% to $1.1 billion in 2024, then rose by 7.31% to $1.2 billion in 2025, then slipped by 0.43% to $1.2 billion in 2026.
• The last three Cost of Revenue figures came in at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.